Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Pfizer Reaffirms CV Disease Commitment With Deal For Akcea's ANGPTL3 Drug

Oct 07 2019

• By Jessica Merrill

Heart health care medical cardiovascular disease concept and organ donor donation for life giving charity campaign with healthy red love heart on aging woman's hand support - Image — Pfizer is going big and broad in cardiovascular disease • Source: Shutterstock

Related Content

Pfizer’s Lipitor Extension Shot Down By Failure Of Torcetrapib Silver Bullet

Dec 11 2006

Akcea C-Suite Upheaval’s Reasons Unclear, Firm Set To Take In More Ionis Programs

Sep 23 2019

Regeneron’s Cholesterol Drug Aces Phase III, Teeing Up US FIling

Aug 15 2019

Related Companies

Pfizer Inc.

Akcea Therapeutics, Inc.

Sanofi

Regeneron Pharmaceuticals, Inc.

Amgen, Inc.

Ionis Pharmaceuticals, Inc.

Additional Topics

Deals Commercial Cardiovascular BioPharmaceutical

More from Cardiovascular

More from Therapeutic Category

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window